NasdaqCM:SNOAPharmaceuticals
Sonoma Pharmaceuticals Third Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag
Sonoma Pharmaceuticals ( NASDAQ:SNOA ) Third Quarter 2025 Results Key Financial Results Revenue: US$3.56m (up 14% from...
Stock Analysis
Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.